Study Epidemioloy TB MDR and Complication in Brain and Spine University Sebelas Maret Surakarta, Indonesia Abstract The World Health Organization (WHO) estimates that each year there are 9 million new TB cases. Annually, TB kills approximately 1.8 million people, making it second only to HIV/AIDS as the leading cause of death from infectious diseases. Among those infected with M. tuberculosis, approximately 50 million are infected with drug-resistant strains. Worldwide, an estimated 5,000,000 cases of MDR-TB emerge each year (5.3% of all new and previously treated TB cases), resulting in 110,000 deaths. MDR-TB is tuberculosis due to organisms that show high-level resistance to both isoniazid and rifampicin, with or without resistance to other anti-TB drugs. The problem of multidrug-resistant tuberculosis has also been identified in patients with tuberculous in the central nervous system (CNS) including the brain and spine tuberculous. Multidrug-resistant CNS tuberculous is often associated with a poor prognosis. CNS tuberculosis is a devastating disease of the central nervous system. It primarily affects the meninges of the brain and spinal cord along with adjacent brain parenchyma. The thoracic spine is involved in 50% of spinal tuberculosis. Whereas the lumbar and cervical spine are each involved in 25% of cases. CNS tuberculosis can manifest in a variety of forms, including tuberculous meningitis, tuberculomas, tuberculous abscesses, and miliary tuberculosis. A meticulous cytologic analysis of cerebrospinal fluid, neuroimaging of the brain and spine, and an appropriate clinical setting are the key factors that help the diagnosis. Keywords: Keywords: CNS Tuberculosis, multidrug-resistant tuberculosis, brain and spine Topic: Medical : basic science, clinical, translational research, medical education, and miscellaneous |
ICOHELICS 2022 Conference | Conference Management System |